ArriVent BioPharma (AVBP) Interest & Investment Income (2023 - 2026)
ArriVent BioPharma (AVBP) posted Interest & Investment Income of $2.8 million for Q2 2026, up 25.8% from $2.22 million a year earlier and up 0.3% from the prior quarter.
Powered by 
Analysis
ArriVent BioPharma (AVBP) Interest & Investment Income (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at ArriVent BioPharma was $12.21 million, up 7.6% year-over-year; for FY2025, it came in at $11.23 million, down 18.8% from FY2024.
- In prior years, ArriVent BioPharma's Interest & Investment Income was $13.82 million in FY2024 (+162.9%) and $5.26 million in FY2023.
- Quarterly Interest & Investment Income has run from a low of $1.02 million in Q2 2023 to a high of $3.82 million in Q2 2024 over five years.
- On a year-over-year basis, Interest & Investment Income has increased in each of the last three quarters, with growth averaging 11.3% over the last eight quarters.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q2 2024, with growth of 275.9%; the weakest was Q2 2025, with a decline of 41.8%.
- According to Business Quant data, Interest & Investment Income for the three prior quarters was $2.79 million (Q1 2026), $3.28 million (Q4 2025) and $3.34 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | ArriVent BioPharma | 690.85 Mn | -714.69 Mn | - | 3.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.06 Mn |
| Jun 30, 2026 | 2.80 Mn |
| Mar 31, 2026 | 2.79 Mn |
| Dec 31, 2025 | 3.28 Mn |
| Sep 30, 2025 | 3.34 Mn |
| Jun 30, 2025 | 2.22 Mn |
| Mar 31, 2025 | 2.39 Mn |
| Dec 31, 2024 | 3.07 Mn |
| Sep 30, 2024 | 3.67 Mn |
| Jun 30, 2024 | 3.82 Mn |
| Mar 31, 2024 | 3.26 Mn |
| Dec 31, 2023 | 1.93 Mn |
| Sep 30, 2023 | 2.32 Mn |
| Jun 30, 2023 | 1.02 Mn |
API Access
ArriVent BioPharma Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=AVBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "AVBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=AVBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();